Background {#Sec1}
==========

Arterial stiffness is an early detectable manifestation of adverse structural and functional changes of the vessel wall \[[@CR1]\].

Insulin resistance can promote arterial stiffness and plaque progression through downregulation of insulin signaling pathways and alterations in lipid metabolism; moreover, inflammatory pathways support the role of insulin resistance in the pathophysiology of aortic stiffness \[[@CR2]\].

Increased arterial stiffness is an early phenomenon that occurs in the impaired glucose metabolic state \[[@CR3]\]. Insulin has acute vasodilator effects that lead to increased arterial distensibility, and this beneficial effect is blunted in insulin-resistant states. Increased stiffness is a feature of insulin resistance \[[@CR4]\].

Chronic hyperglycemia and hyperinsulinemia increase the local activity of the renin-angiotensin aldosterone system and expression of angiotensin type I receptor in vascular tissue, promoting the development of wall hypertrophy and fibrosis \[[@CR5]\].

In addition, low-grade inflammation and endothelial dysfunction, which are interrelated, may also explain, at least in part, the increase in arterial stiffness related to diabetes and metabolic syndrome \[[@CR6]\].

Greater arterial stiffness increases cardiovascular disease risk by increasing blood pressure, increasing ventricular hypertrophy, decreasing coronary perfusion, and increasing the risk of stroke \[[@CR7]\].

Many methods have been used to assess aortic distensibility (AD), but CMR has the unique ability to provide both local and regional direct noninvasive measures of aortic function. Lumen area changes (aortic strain) over the cardiac cycle can be acquired with high temporal and spatial resolution, and aortic distensibility can be measured in different locations \[[@CR8]\].

Methods {#Sec2}
=======

Study subjects {#Sec3}
--------------

Ninety-eight patients were enrolled: 8 women and 90 men diagnosed with CCAD (patients with documented CAD and stable for 3 months) underwent CMR. The study was approved by our local ethics committee, and written consent was obtained from each patient. The patients were classified into 52 prediabetics with elevated HbA1C (defined range 5.7--6.4%) (study group) and 46 patients with normal HbA1C (control group). The exclusion criteria included age \< 18 years, any contraindications to MRI, and a history of DM, HTN, renal impairment, LVEF less than 45%, and aortic diseases (more than moderate aortic regurgitation; more than mild aortic stenosis and aortic aneurysm).

Laboratory investigations {#Sec4}
-------------------------

Glycosylated hemoglobin (HbA1C) for all patients was analyzed by radioimmunoassays by COBAS INTEGRA 400 PLUS/800 analyzers (Roche, USA) through the Assiut University laboratory. Complete blood count (CBC), serum urea and creatinine, and a lipid profile including total cholesterol (TC), triglycerides (TG), HDL-c (high-density lipoprotein cholesterol), and LDL-c (low-density lipoprotein cholesterol) for all patients were analyzed by Hitachi Cobas c 501 analyzers.

Echocardiography {#Sec5}
----------------

All patients underwent echocardiography. The same operator and same device (GE Vivid S5) was used to minimize interobservational variability. LV volumes were measured using 2D echocardiography. Significant aortic regurge was excluded by color Doppler study of the aorta in the parasternal long-axis (PLAX) and apical 5-chamber views. Aortic diameters were measured and included the aortic root, ascending aorta in PLAX view, arch, and descending aorta in suprasternal view.

Assessment of aortic distensibility by CMR {#Sec6}
------------------------------------------

CMR acquisition was performed with Ingenia Philips 1.5 Tesla MRI scanner. Electrocardiogram (ECG)-gated gradient-echo phase-contrast cine sequence with velocity encoding FFE with breath-holding was taken at 2 levels: one in the axial plane at the level of the sinotubular junction for calculation of aortic root luminal diameter (by the average of the three end-diastolic cusp-commissure measurements) and another perpendicular to the descending aorta at the level of the bifurcation of the pulmonary artery for calculation of ascending and descending aorta luminal diameters, with a repetition time equal to the RR interval (in ms) and a 14-ms echo time, 256 × 256 matrix size, 300-mm field of view, 8-mm slice thickness, and 20° flip angle. Acquisition was performed using two views for appropriate alignment of the cut (for example, using an LVOT view and a 3-chamber view for the aortic root and using a coronal view and LVOT view for the ascending aorta). Modulus images of the cine phase-contrast sequences were used to calculate the corresponding aortic section luminal diameter. Aortic contours were automatically traced throughout the cardiac cycle and then manually corrected (if needed) using QFLOW software (Phillips, the Netherlands).

The maximum and minimum ascending and descending aortic luminal areas were determined from the maximum and minimum cross-sectional areas of the corresponding aortic section, respectively, and then, we obtained a curve and generated a table (plotting the luminal area against trigger time) (Fig. [1](#Fig1){ref-type="fig"}). Using this curve, we measured the aortic distensibility of the corresponding aortic section with the following equation: 1000× (systolic aortic area (cm^2^) − diastolic aortic area (cm^2^)/(diastolic aortic area (cm^2^) × pulse pressure (mmHg) \[[@CR8]\].Systolicaorticareacm^2^-Diastolicaorticareacm^2^*Distolicaorticarea*cm^2^xPulsepressure(mmHg) Fig. 1Snapshot image from Philips Q flow software. TOP: chart illustrating cross-sectional area change of ascending and descending aorta at the level of pulmonary artery bifurcation during the cardiac cycle. Bottom A modulus image of Q-flow sequence of ascending and descending aorta at the level of pulmonary artery bifurcation with contouring

Blood pressure (BP) was measured twice at the time of the scan, and the average reading was used. Pulse pressure was calculated as the difference between systolic and diastolic BP.

Results {#Sec7}
=======

Patient characteristics {#Sec8}
-----------------------

The mean age of the patients was 51.04 ± 6.44 years, and the majority of them were males (92.3%), while the mean age of the controls was 49.30 ± 6.31 years, and the majority (91.3%) of them were males. The mean body mass index was significantly higher in the patients with prediabetes (30.07 ± 4.76 kg/m^2^) than in the controls (25.62 ± 3.02, *P* \< 0.001). Additionally, the patients with prediabetes had significantly higher waist circumference than the controls (108.5 ± 7.13 cm versus 93.70 ± 7.70 cm; *P* \< 0.001).

The patients with prediabetics had significantly higher diastolic blood pressure and pulse pressure than the controls (*P* \< 0.001), but systolic blood pressure was not significantly different between the two groups (*P* = 0.91) (Table [1](#Tab1){ref-type="table"}). Table 1Clinical characteristics of the study and control groupsPatient characteristicsStudy groupControl group*P* valueAge (years)51.04 ± 6.4449.30 ± 6.310.34BMI30.07 ± 4.7625.62 ± 3.02\< 0.001Waist circumference (cm)108.5 ± 7.1393.70 ± 7.70 cm\< 0.001SBP118.46 ± 5.24118.68 ± 4.560.91DBP76.92 ± 7.3582.60 ± 4.48\< 0.001PP41.53 ± 5.4336.08 ± 4.99\< 0.001Lipid profileGlycosylated hemoglobin (Hgb A1c)6.02 ± 0.235.22 ± 0.41\< 0.001Cholesterol (mg/dl)200.11 ± 39.37183.20 ± 40.300.22Triglyceride (mg/dl)157.19 ± 41.60144.13 ± 29.880.29HDL (mg/dl)37.73 ± 6.7845.80 ± 4.69\< 0.001LDL (mg/dl)130.80 ± 28.4099 ± 19.17\< 0.001Echo parametersEjection fraction (%)53.23 ± 5.0755.80 ± 2.040.09Aortic root (cm)3.16 ± 0.413.08 ± 0.350.45Left atrium (cm)3.98 ± 0.64.28 ± 0.700.13

There were no significant differences between the two groups regarding aortic root diameter, aortic velocity index, left atrium diameter, and ejection fraction (Table [1](#Tab1){ref-type="table"}).

Hemoglobin and creatinine levels were not significantly different between the two groups (*P* \> 0.05). The study showed that cholesterol (200.11 ± 39.37 versus 183.20 ± 40.30, *P* = 0.22) and triglyceride (157.19 ± 41.60 versus 144.13 ± 29.88, *P* = 0.29) levels were non-significantly higher in the study group than in the control group, while LDL levels were significantly higher in the study group than in the control group (130.80 ± 28.40 versus 99 ± 19.17, *P* \< 0.001, respectively). HDL levels were significantly lower in the study group than in the control group (37.73 ± 6.78 versus 45.80 ± 4.69, *P* \< 0.0001, respectively) (Table [1](#Tab1){ref-type="table"}).

Aortic distensibility by CMR {#Sec9}
----------------------------

Aortic distensibility values at different points (aortic root, ascending aorta, and descending aorta) were significantly lower in the prediabetes patients than in the controls (*P* \< 0.001) (Table [2](#Tab2){ref-type="table"}). Moreover, these values had a strong significant negative correlation with the level of glycosylated hemoglobin (*P \<* 0.001) (Table [3](#Tab3){ref-type="table"}). Table 2Aortic distensibility in study and control groupsDistensibilityStudy group (*n* = 52)Control group (*n* = 46)*P* valueAR distensibilityKpa^-1^ × 10^-3^13.93 ± 5.1734.30 ± 9.65\< 0.001AA distensibilityKpa^-1^ × 10^-3^13.17 ± 4.8128.10 ± 8.33\< 0.001DA distensibilityKpa^-1^ × 10^-3^18.12 ± 4.3433.08 ± 7.57\< 0.001 Table 3Correlation between aortic distensibility, HbA1C, age, BMI, and waist circumferenceAortic distensibility (kpa^-1^ × 10^-3^)Aortic rootAscending aortaDescending aorta*RP* value*rP* value*rP* valueHbA1C− 0.66\< 0.001− 0.68\< 0.001− 0.58\< 0.001Age− 0.030.83− 0.400.03− 0.080.56BMI− 0.43\< 0.001− 0.38\< 0.001− 0.41\< 0.001Waist circumference− 0.74\< 0.001− 0.70\< 0.001− 0.60\< 0.001

Correlation between aortic distensibility and glycosylated hemoglobin {#Sec10}
---------------------------------------------------------------------

Aortic distensibility values in different areas (aortic root, ascending aorta, and descending aorta) had strong significant negative correlations with the levels of glycosylated hemoglobin (*P \<* 0.001) (*r* = 66, 68, 58, respectively) (Table [3](#Tab3){ref-type="table"}, Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Correlation between Hba1C and aortic distensibility at different levels

Relationship between aortic distensibility and age {#Sec11}
--------------------------------------------------

Aortic distensibility at the aortic root and descending aorta had no significant correlations with the age of the subjects (*P \>* 0.05), but distensibility of the ascending aorta had a moderately significant correlation with age (*r* = − 0.40, *P* = 0.03) (Table [3](#Tab3){ref-type="table"}).

Correlation between aortic distensibility and body mass index {#Sec12}
-------------------------------------------------------------

Aortic distensibility in different areas (aortic root, ascending aorta, and descending aorta) had significant negative correlations with body mass index values (*P \<* 0.001) (Table [3](#Tab3){ref-type="table"}). Moreover, aortic distensibility in different areas (aortic root, ascending aorta, and descending aorta) had significant negative correlations with waist circumference values (*P \<* 0.001) (Table [3](#Tab3){ref-type="table"}).

Using multivariate regression analysis, the following were predictors for aortic stiffness in the prediabetes patients with an adjusted *R*^2^ value of 0.59: body mass index, glycosylated Hb, and waist circumference (Table [4](#Tab4){ref-type="table"}). Table 4Multivariate regression analysis for prediction of aortic stiffnessVariablesOdd's ratio95% confidence interval*P* valueBody mass index1.451.34--3.450.01Glycosylated Hb2.182.01--5.450.01HDL0.450.33--1.980.45LDL1.560.87--1.990.29Waist circumference1.221.11--2.100.01

Relationship between aortic distensibility and metabolic syndrome {#Sec13}
-----------------------------------------------------------------

Twenty-eight patients were diagnosed with metabolic syndrome (25 from the study group and 3 from the normal glycemic group) based on the criteria of the modified ATP III (Adult Treatment Panel III) published by the IDF (International Diabetes Federation) in 2005 \[[@CR9]\]. Aortic distensibility values at different points (aortic root, ascending aorta, and descending aorta) were significantly lower in those patients with metabolic syndrome than in those without metabolic syndrome (AR: 13.36 vs 17.05, *P* \< 0.01; AA: 12.48 vs 16.93, *P* = 0.04; DA: 18.03 vs 18.62, *P* = 0.01) (Table [5](#Tab5){ref-type="table"}). Table 5Aortic distensibility in studied patients based on the presence of the metabolic syndromeWith metabolic syndromeWithout metabolic syndrome*P* valueAR distensibilityKpa^-1^ × 10^-3^13.36 ± 5.3817.05 ± 2.310.01AA distensibilityKpa^-1^ × 10^-3^12.48 ± 4.8316.93 ± 2.660.04DA distensibilityKpa^-1^ × 10^-3^18.03 ± 4.5918.62 ± 2.970.01

Discussion {#Sec14}
==========

In this study, aortic distensibility was significantly lower in the prediabetes group than in the control group. We also found a significant negative correlation between aortic distensibility and the levels of HbA1C. Impaired glucose tolerance alters the mechanical properties of the interstitial tissue of the vascular wall; moreover, it enhances nonenzymatic glycation of proteins. Nonenzymatic glycation leads to the formation of increased collagen crosslinks that result in increased arterial stiffness \[[@CR10]--[@CR12]\].

In the current study, all patients' ages were between the 3rd and 5th decades to avoid age effects on aortic elastic properties; that is, in individuals ≥ 55 years of age, PP increased more markedly and strain continued to decline, leading to lesser sensitivity of aortic distensibility as a marker of arterial aging beyond this age \[[@CR13]\].

The current study showed that BMI and WC were higher in the study group than in the control group. These findings are consistent with the results of Marini et al., who assessed cardiometabolic risk profiles in individuals with prediabetes \[[@CR12]\]. In our study, there was no significant difference in systolic blood pressure (SBP) between the study and control groups; on the contrary, diastolic blood pressure (DBP) and pulse pressure were different, which was not consistent with a randomized controlled trial that assessed BP variability in individuals with prediabetes that showed higher SBP and DBP, which may be explained by the nonuse of ambulatory BP monitoring in our study \[[@CR13]\].

In the current study, aortic distensibility (AD) values at different locations (aortic root, ascending aorta, and descending aorta) had significant negative correlations with waist circumference, which was consistent with another study that assessed AD in untreated essential hypertension patients, although they had measured aortic PWV with the SphygmoCor VX system for aortic stiffness assessment \[[@CR14]\].

Our control group demonstrated AA distensibility of 28.10 ± 8.33 Kpa^-1^ × 10^-3^ (*P* \< 0.001) and DA distensibility of 33.08 ± 7.57 Kpa^-1^ × 10^-3^ (*P* \< 0.001), which is consistent with the values reported by Redheuil et al. in a cross-sectional randomized controlled trial that assessed distensibility by MRI (21.3 ± 2 Kpa^-1^ × 10^-3,^ *P* \< 0.0001) \[[@CR8]\].

In our study, aortic distensibility at the aortic root and descending aorta was not significantly correlated with the age of the subjects, AR (*r* = − 0.03, *P* \< 0.83), and DA (*r* = − 0.08, *P* \< 0.56); however, the distensibility of the ascending aorta had a moderate significant correlation with age, which may be attributed to the higher elastin content of the ascending aorta that may decrease with age \[[@CR15]\].

Our results were also consistent with the MESA study that used fasting glucose levels to diagnose glucose intolerance and its effect on proximal thoracic aortic distensibility by MRI, which found that glucose status had no effect on AD in subjects aged \> 65 years old, while aortic distensibility values in the age-matched subgroup were similar to our results (2.11 × 10^-3^ mmHg^-1^ for IFG, *P* = 0.01) \[[@CR15]\].

The present study showed that patients with metabolic syndrome have lower AD and that waist circumference, BMI, and HbA1C were stronger predictors of worse AD. Metabolic syndrome increases the risk of CV disease in many ways and increases arterial stiffness in all ages \[[@CR16]--[@CR18]\]. The sympathetic nervous system, renin-angiotensin system, inflammatory cytokines, and hyperdynamic circulation play an important pathophysiologic role in metabolic syndrome \[[@CR19]\].

Aortic elasticity indices have been linked to the occurrence of CV events and target organ damage in prediabetics, diabetics, and hypertensives, which emphasizes the importance of assessing aortic distensibility (as one of aortic elasticity markers) in these patients \[[@CR20], [@CR21]\].

Conclusions {#Sec15}
===========

Individuals with prediabetes and those with metabolic syndrome have worse aortic elastic properties than those with normal glycemic index values. CMR provides a relatively easy and reproducible method for the assessment of local aortic function in comparison to the cumbersome old methods with commonly encountered limitations and pitfalls \[[@CR22]\].
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